Maria E. González

1.5k total citations
30 papers, 1.1k citations indexed

About

Maria E. González is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maria E. González has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maria E. González's work include Epigenetics and DNA Methylation (10 papers), Connective Tissue Growth Factor Research (6 papers) and RNA modifications and cancer (5 papers). Maria E. González is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Connective Tissue Growth Factor Research (6 papers) and RNA modifications and cancer (5 papers). Maria E. González collaborates with scholars based in United States, Mexico and Estonia. Maria E. González's co-authors include Celina G. Kleer, Kathy A. Toy, Wei Huang, Alejandra C. Ventura, Kelley M. Kidwell, Sofía D. Merajver, Elizabeth M. Petty, Lisa M. Privette Vinnedge, Heather M. Moore and Mousumi Banerjee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Maria E. González

28 papers receiving 1.1k citations

Peers

Maria E. González
Michelle Van Scoyk United States
Maria E. González
Citations per year, relative to Maria E. González Maria E. González (= 1×) peers Michelle Van Scoyk

Countries citing papers authored by Maria E. González

Since Specialization
Citations

This map shows the geographic impact of Maria E. González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. González more than expected).

Fields of papers citing papers by Maria E. González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria E. González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. González. The network helps show where Maria E. González may publish in the future.

Co-authorship network of co-authors of Maria E. González

This figure shows the co-authorship network connecting the top 25 collaborators of Maria E. González. A scholar is included among the top collaborators of Maria E. González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria E. González. Maria E. González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yunyun, Rui Cheng, Yuqing Wang, et al.. (2024). Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. EBioMedicine. 100. 104972–104972. 23 indexed citations
2.
González, Maria E., Giuseppina Daniela Naimo, Talha Anwar, et al.. (2022). EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progression. iScience. 25(8). 104827–104827. 13 indexed citations
3.
Tran, Mai, et al.. (2021). The matricellular protein CCN6 differentially regulates mitochondrial metabolism in normal epithelium and in metaplastic breast carcinomas. Journal of Cell Communication and Signaling. 16(3). 433–445. 2 indexed citations
4.
Anwar, Talha, Maria E. González, & Celina G. Kleer. (2021). Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer. American Journal Of Pathology. 191(5). 774–783. 33 indexed citations
5.
Skala, Stephanie L., Maria E. González, Sabra Djomehri, et al.. (2020). Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes. Breast Cancer. 28(2). 496–505. 11 indexed citations
6.
Hsu, Yu-Han H., Christina M. Astley, Joanne B. Cole, et al.. (2020). Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome. International Journal of Obesity. 44(7). 1596–1606. 17 indexed citations
7.
Anwar, Talha, Sabra Djomehri, Maria E. González, et al.. (2020). Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana. Modern Pathology. 33(8). 1537–1545. 7 indexed citations
8.
Djomehri, Sabra, Maria E. González, Felipe da Veiga Leprevost, et al.. (2020). Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors. Nature Communications. 11(1). 1723–1723. 64 indexed citations
9.
Kim, Wondong, Amy Deik, Clicerio González, et al.. (2019). Polyunsaturated Fatty Acid Desaturation Is a Mechanism for Glycolytic NAD+ Recycling. Cell Metabolism. 29(4). 856–870.e7. 102 indexed citations
10.
Hsu, Yu-Han H., Claire Churchhouse, Tune H. Pers, et al.. (2019). PAIRUP-MS: Pathway analysis and imputation to relate unknowns in profiles from mass spectrometry-based metabolite data. PLoS Computational Biology. 15(1). e1006734–e1006734. 15 indexed citations
11.
González, Maria E., Stephanie L. Skala, Mai Tran, et al.. (2018). CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast. Breast Cancer Research and Treatment. 172(3). 577–586. 21 indexed citations
12.
Anwar, Talha, James Ropa, Yu‐Chih Chen, et al.. (2018). p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis. Nature Communications. 9(1). 2801–2801. 92 indexed citations
13.
Huang, Wei, et al.. (2016). MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas. Oncogene. 36(16). 2275–2285. 21 indexed citations
14.
Moore, Heather M., Maria E. González, Kathy A. Toy, et al.. (2013). EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Research and Treatment. 138(3). 741–752. 41 indexed citations
15.
González, Maria E., et al.. (2011). Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer. Cancer Research. 71(6). 2360–2370. 89 indexed citations
16.
Hunt, Kelly J., et al.. (2011). Diabetes is More Lethal in Mexicans and Mexican-Americans Compared to Non-Hispanic Whites. Annals of Epidemiology. 21(12). 899–906. 21 indexed citations
17.
Huang, Wei, Maria E. González, Kathy A. Toy, Mousumi Banerjee, & Celina G. Kleer. (2010). Blockade of CCN6 (WISP3) Activates Growth Factor–Independent Survival and Resistance to Anoikis in Human Mammary Epithelial Cells. Cancer Research. 70(8). 3340–3350. 29 indexed citations
18.
González, Maria E., X. Li, Kathy A. Toy, et al.. (2008). Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene. 28(6). 843–853. 148 indexed citations
19.
Vinnedge, Lisa M. Privette, Maria E. González, Lei Ding, Celina G. Kleer, & Elizabeth M. Petty. (2007). Altered Expression of the Early Mitotic Checkpoint Protein, CHFR, in Breast Cancers: Implications for Tumor Suppression. Cancer Research. 67(13). 6064–6074. 42 indexed citations
20.
González, Maria E., et al.. (2007). High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes. Cancer Research. 67(18). 8554–8564. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026